Free Trial

electroCore Q3 2023 Earnings Report

electroCore logo
$15.27 +0.75 (+5.17%)
(As of 12/20/2024 05:31 PM ET)

electroCore EPS Results

Actual EPS
-$0.68
Consensus EPS
-$0.64
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A

electroCore Revenue Results

Actual Revenue
$4.51 million
Expected Revenue
$3.98 million
Beat/Miss
Beat by +$530.00 thousand
YoY Revenue Growth
N/A

electroCore Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!

electroCore Earnings Headlines

HC Wainwright Forecasts Stronger Earnings for electroCore
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
NeuroMetrix, Inc.: NeuroMetrix to be Acquired by electroCore
electroCore donates gammaCore Sapphire for real world evalution of nVNS
See More electroCore Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like electroCore? Sign up for Earnings360's daily newsletter to receive timely earnings updates on electroCore and other key companies, straight to your email.

About electroCore

electroCore (NASDAQ:ECOR), a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

View electroCore Profile

More Earnings Resources from MarketBeat

Upcoming Earnings